Cirius Therapeutics, Inc. IPO Research Information

Cirius Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Cirius Therapeutics, Inc. , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Cirius Therapeutics, Inc.	CSTX - NASDAQ	Withdrawn	$0.00	$0.00	Withdrawn
Underwriter(s): Citigroup, Credit Suisse
Co-Manager(s): Needham & Co., Wedbush PacGrow
Industry: Health Care
Filing(s): Filed 2019-01-11 Updated Prospectus 2019-02-13 Withdrawn 2019-12-20

About Cirius Therapeutics, Inc. (adapted from Cirius Therapeutics, Inc. prospectus):
They are a clinical-stage pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and metabolic diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CSTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.